Literature DB >> 8432857

Characterization of cellular defects of insulin action in type 2 (non-insulin-dependent) diabetes mellitus.

S Del Prato1, R C Bonadonna, E Bonora, G Gulli, A Solini, M Shank, R A DeFronzo.   

Abstract

Seven non-insulin-dependent diabetes mellitus (NIDDM) patients participated in three clamp studies performed with [3-3H]- and [U-14C]glucose and indirect calorimetry: study I, euglycemic (5.2 +/- 0.1 mM) insulin (269 +/- 39 pM) clamp; study II, hyperglycemic (14.9 +/- 1.2 mM) insulin (259 +/- 19 pM) clamp; study III, euglycemic (5.5 +/- 0.3 mM) hyperinsulinemic (1650 +/- 529 pM) clamp. Seven control subjects received a euglycemic (5.1 +/- 0.2 mM) insulin (258 +/- 24 pM) clamp. Glycolysis and glucose oxidation were quantitated from the rate of appearance of 3H2O and 14CO2; glycogen synthesis was calculated as the difference between body glucose disposal and glycolysis. In study I, glucose uptake was decreased by 54% in NIDDM vs. controls. Glycolysis, glycogen synthesis, and glucose oxidation were reduced in NIDDM patients (P < 0.05-0.001). Nonoxidative glycolysis and lipid oxidation were higher. In studies II and III, glucose uptake in NIDDM was equal to controls (40.7 +/- 2.1 and 40.7 +/- 1.7 mumol/min.kg fat-free mass, respectively). In study II, glycolysis, but not glucose oxidation, was normal (P < 0.01 vs. controls). Nonoxidative glycolysis remained higher (P < 0.05). Glycogen deposition increased (P < 0.05 vs. study I), and lipid oxidation remained higher (P < 0.01). In study III, hyperinsulinemia normalized glycogen formation, glycolysis, and lipid oxidation but did not normalize the elevated nonoxidative glycolysis or the decreased glucose oxidation. Lipid oxidation and glycolysis (r = -0.65; P < 0.01), and glucose oxidation (r = -0.75; P < 0.01) were inversely correlated. In conclusion, in NIDDM: (a) insulin resistance involves glycolysis, glycogen synthesis, and glucose oxidation; (b) hyperglycemia and hyperinsulinemia can normalize total body glucose uptake; (c) marked hyperinsulinemia normalizes glycogen synthesis and total flux through glycolysis, but does not restore a normal distribution between oxidation and nonoxidative glycolysis; (d) hyperglycemia cannot overcome the defects in glucose oxidation and nonoxidative glycolysis; (e) lipid oxidation is elevated and is suppressed only with hyperinsulinemia.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8432857      PMCID: PMC287962          DOI: 10.1172/JCI116226

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  47 in total

1.  Defective insulin receptor tyrosine kinase in human skeletal muscle in obesity and type 2 (non-insulin-dependent) diabetes mellitus.

Authors:  P Arner; T Pollare; H Lithell; J N Livingston
Journal:  Diabetologia       Date:  1987-06       Impact factor: 10.122

2.  Effects of insulin on skeletal muscle glucose storage, oxidation, and glycolysis in humans.

Authors:  D E Kelley; J P Reilly; T Veneman; L J Mandarino
Journal:  Am J Physiol       Date:  1990-06

Review 3.  New concepts in the pathogenesis and treatment of noninsulin-dependent diabetes mellitus.

Authors:  R A DeFronzo; E Ferrannini; V Koivisto
Journal:  Am J Med       Date:  1983-01-17       Impact factor: 4.965

4.  Hyperglycemia normalizes insulin-stimulated skeletal muscle glucose oxidation and storage in noninsulin-dependent diabetes mellitus.

Authors:  D E Kelley; L J Mandarino
Journal:  J Clin Invest       Date:  1990-12       Impact factor: 14.808

5.  Relative contribution of glycogen synthesis and glycolysis to insulin-mediated glucose uptake. A dose-response euglycemic clamp study in normal and diabetic rats.

Authors:  L Rossetti; A Giaccari
Journal:  J Clin Invest       Date:  1990-06       Impact factor: 14.808

6.  Effects of insulin on peripheral and splanchnic glucose metabolism in noninsulin-dependent (type II) diabetes mellitus.

Authors:  R A DeFronzo; R Gunnarsson; O Björkman; M Olsson; J Wahren
Journal:  J Clin Invest       Date:  1985-07       Impact factor: 14.808

7.  Postprandial hyperglycemia in patients with noninsulin-dependent diabetes mellitus. Role of hepatic and extrahepatic tissues.

Authors:  R G Firth; P M Bell; H M Marsh; I Hansen; R A Rizza
Journal:  J Clin Invest       Date:  1986-05       Impact factor: 14.808

8.  Role of free fatty acids and insulin in determining free fatty acid and lipid oxidation in man.

Authors:  L C Groop; R C Bonadonna; M Shank; A S Petrides; R A DeFronzo
Journal:  J Clin Invest       Date:  1991-01       Impact factor: 14.808

9.  Effects of insulin infusion on human skeletal muscle pyruvate dehydrogenase, phosphofructokinase, and glycogen synthase. Evidence for their role in oxidative and nonoxidative glucose metabolism.

Authors:  L J Mandarino; K S Wright; L S Verity; J Nichols; J M Bell; O G Kolterman; H Beck-Nielsen
Journal:  J Clin Invest       Date:  1987-09       Impact factor: 14.808

10.  An in vitro human muscle preparation suitable for metabolic studies. Decreased insulin stimulation of glucose transport in muscle from morbidly obese and diabetic subjects.

Authors:  G L Dohm; E B Tapscott; W J Pories; D J Dabbs; E G Flickinger; D Meelheim; T Fushiki; S M Atkinson; C W Elton; J F Caro
Journal:  J Clin Invest       Date:  1988-08       Impact factor: 14.808

View more
  35 in total

Review 1.  Alterations of glucose metabolism in type 2 diabetes mellitus. An overview.

Authors:  Riccardo C Bonadonna
Journal:  Rev Endocr Metab Disord       Date:  2004-05       Impact factor: 6.514

2.  Intracellular lactate- and pyruvate-interconversion rates are increased in muscle tissue of non-insulin-dependent diabetic individuals.

Authors:  A Avogaro; G Toffolo; M Miola; A Valerio; A Tiengo; C Cobelli; S Del Prato
Journal:  J Clin Invest       Date:  1996-07-01       Impact factor: 14.808

3.  Peripheral but not hepatic insulin resistance in mice with one disrupted allele of the glucose transporter type 4 (GLUT4) gene.

Authors:  L Rossetti; A E Stenbit; W Chen; M Hu; N Barzilai; E B Katz; M J Charron
Journal:  J Clin Invest       Date:  1997-10-01       Impact factor: 14.808

4.  Plasma lactate and diabetes risk in 8045 participants of the atherosclerosis risk in communities study.

Authors:  Stephen P Juraschek; Elizabeth Selvin; Edgar R Miller; Frederick L Brancati; J Hunter Young
Journal:  Ann Epidemiol       Date:  2013-10-05       Impact factor: 3.797

Review 5.  Role of insulin resistance in the pathogenesis of NIDDM.

Authors:  H Yki-Järvinen
Journal:  Diabetologia       Date:  1995-12       Impact factor: 10.122

Review 6.  Estimation of insulin sensitivity in children: methods, measures and controversies.

Authors:  Rebecca J Brown; Jack A Yanovski
Journal:  Pediatr Diabetes       Date:  2014-04-23       Impact factor: 4.866

7.  Regulation of endogenous glucose production by glucose per se is impaired in type 2 diabetes mellitus.

Authors:  M Mevorach; A Giacca; Y Aharon; M Hawkins; H Shamoon; L Rossetti
Journal:  J Clin Invest       Date:  1998-08-15       Impact factor: 14.808

8.  AMP-activated protein kinase (AMPK)α2 plays a role in determining the cellular fate of glucose in insulin-resistant mouse skeletal muscle.

Authors:  R S Lee-Young; J S Bonner; W H Mayes; I Iwueke; B A Barrick; C M Hasenour; L Kang; D H Wasserman
Journal:  Diabetologia       Date:  2012-12-08       Impact factor: 10.122

9.  Multiple defects of both hepatic and peripheral intracellular glucose processing contribute to the hyperglycaemia of NIDDM.

Authors:  A Vaag; F Alford; F L Henriksen; M Christopher; H Beck-Nielsen
Journal:  Diabetologia       Date:  1995-03       Impact factor: 10.122

Review 10.  Pathogenesis of insulin resistance in skeletal muscle.

Authors:  Muhammad A Abdul-Ghani; Ralph A DeFronzo
Journal:  J Biomed Biotechnol       Date:  2010-04-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.